Borhani Amir A, Patel Naishal, Patel Vedang, Haghshomar Maryam, Grimaldi Gregory, Miller Frank H, McGinty Katrina
Northwestern University Feinberg School of Medicine, Chicago, USA.
University of North Carolina at Chapel Hill, Chapel Hill, USA.
Abdom Radiol (NY). 2025 Apr;50(4):1547-1554. doi: 10.1007/s00261-024-04618-9. Epub 2024 Sep 30.
Several pseudolesions mimicking malignancy have been reported in cirrhotic and non-cirrhotic livers. Pericholecystic regeneration is among those pseudolesions and can occasionally mimic malignancy. Herein we present a case series comprised of 10 cirrhotic patients (majority due to alcoholic liver disease [ALD] or metabolic dysfunction associated steatotic liver disease [MASLD]) with pericholecystic observations initially categorized as highly suspicious for HCC (LR-4 and LR-5) due to their suspicious enhancement pattern which were later proven to be benign based on biopsy, transplantation or imaging criteria (stability of size and morphology on serial CT or MRI for > 2 years). These observations ranged 2-6.3 cm in size, were multiple in most patients and universally resulted in indentations of gallbladder. Arterial phase hyperenhancement and washout, features usually attributed to hepatocellular carcinoma (HCC), were seen in most patients. However, ancillary features of malignancy such as diffusion restriction, increased T2 signal, and hypointensity on hepatobiliary phase MRI were not present. Pericholecystic observations, in particular in the setting of ALD and MASLD, should be carefully assessed and possibility of pseudolesion should be considered especially when the observations are multiple, cause indentation of gallbladder, and lack ancillary features of malignancy.
在肝硬化和非肝硬化肝脏中,已报道了几种类似恶性肿瘤的假病变。胆囊周围再生属于这些假病变之一,偶尔可类似恶性肿瘤。在此,我们报告了一个病例系列,包括10例肝硬化患者(大多数因酒精性肝病[ALD]或代谢功能障碍相关脂肪性肝病[MASLD]),其胆囊周围病变最初因可疑的强化模式而被归类为高度怀疑肝癌(LR-4和LR-5),但后来经活检、移植或影像学标准(连续CT或MRI上大小和形态稳定>2年)证实为良性。这些病变大小在2-6.3厘米之间,大多数患者为多发,普遍导致胆囊受压。大多数患者可见动脉期高增强和廓清,这些特征通常归因于肝细胞癌(HCC)。然而,不存在恶性肿瘤的辅助特征,如扩散受限、T2信号增加和肝胆期MRI低信号。胆囊周围病变,特别是在ALD和MASLD背景下,应仔细评估,尤其当病变为多发、导致胆囊受压且缺乏恶性肿瘤辅助特征时,应考虑假病变的可能性。